Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APC(min) mouse model of spontaneous familial adenomatous polyposis

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: onr:"swepub:oai:DiVA.org:oru-53878" > Oral perfluorooctan...

1 av 1
Föregående post
Nästa post
Till träfflistan

Wimsatt, JeffreyDepartment of Medicine, School of Medicine, West Virginia University, Morgantown, USA; Department of Epidemiology, School of Public Health, West Virginia University, Morgantown, USA; West Virginia University, Morgantown, USA (författare)

Oral perfluorooctane sulfonate (PFOS) lessens tumor development in the APC(min) mouse model of spontaneous familial adenomatous polyposis

Artikel/kapitelEngelska2016

Förlag, utgivningsår, omfång ...

2016-12-08
London, United Kingdom :BioMed Central,2016
printrdacarrier

Nummerbeteckningar

LIBRIS-ID:oai:DiVA.org:oru-53878
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-53878URI
https://doi.org/10.1186/s12885-016-2861-5DOI

Kompletterande språkuppgifter

Språk:engelska
Sammanfattning på:engelska

Ingår i deldatabas

SwePubSwePub

Klassifikation

Ämneskategori:ref swepub-contenttype
Ämneskategori:art swepub-publicationtype

Anmärkningar

Funding Agency:NIH U54GM104942
Background: Colorectal cancer is the second most common cause of cancer deaths for both men and women, and the third most common cause of cancer in the U.S. Toxicity of current chemotherapeutic agents for colorectal cancer, and emergence of drug resistance underscore the need to develop new, potentially less toxic alternatives. Our recent cross-sectional study in a large Appalachian population, showed a strong, inverse, dose-response association of serum perfluorooctane sulfonate (PFOS) levels to prevalent colorectal cancer, suggesting PFOS may have therapeutic potential in the prevention and/or treatment of colorectal cancer. In these preliminary studies using a mouse model of familial colorectal cancer, the APC(min) mouse, and exposures comparable to those reported in human populations, we assess the efficacy of PFOS for reducing tumor burden, and evaluate potential dose-response effects.Methods: At 5-6 weeks of age, APC(min) mice were randomized to receive 0, 20, 250 mg PFOS/kg (females) or 0, 10, 50 and 200 mg PFOS/kg (males) via their drinking water. At 15 weeks of age, gastrointestinal tumors were counted and scored and blood PFOS levels measured.Results: PFOS exposure was associated with a significant, dose-response reduction in total tumor number in both male and female mice. This inverse dose-response effect of PFOS exposure was particularly pronounced for larger tumors (r(2) for linear trend = 0.44 for males, p's <0.001).Conclusions: The current study in a mouse model of familial adenomatous polyposis offers the first experimental evidence that chronic exposure to PFOS in drinking water can reduce formation of gastrointestinal tumors, and that these reductions are both significant and dose-dependent. If confirmed in further studies, these promising findings could lead to new therapeutic strategies for familial colorectal cancer, and suggest that PFOS testing in both preventive and therapeutic models for human colorectal cancer is warranted.

Ämnesord och genrebeteckningar

MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Cancer och onkologi hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology hsv//eng
APCmin mouse
Perfluorooctane sulfonate
PFOS
Colorectal cancer
Dose–response
Gender
Onkologi
Oncology

Biuppslag (personer, institutioner, konferenser, titlar ...)

Villers, MeghanDepartment of Medicine, School of Medicine, West Virginia University, Morgantown, USA (författare)
Thomas, LaurelDepartment of Medicine, School of Medicine, West Virginia University, Morgantown, USA (författare)
Kamarec, StaceyDepartment of Medicine, School of Medicine, West Virginia University, Morgantown, USA (författare)
Montgomery, CaitlinDepartment of Medicine, School of Medicine, West Virginia University, Morgantown, USA (författare)
Yeung, Leo W. Y.,1981-Örebro universitet,Institutionen för naturvetenskap och teknik,Man-Technology-Environment (MTM) Research Centre(Swepub:oru)lyg (författare)
Hu, YanqingDepartment of Statistics, West Virginia University, Morgantown, USA (författare)
Innes, KimDepartment of Epidemiology, School of Public Health, West Virginia University, Morgantown, USA (författare)
Department of Medicine, School of Medicine, West Virginia University, Morgantown, USA; Department of Epidemiology, School of Public Health, West Virginia University, Morgantown, USA; West Virginia University, Morgantown, USADepartment of Medicine, School of Medicine, West Virginia University, Morgantown, USA (creator_code:org_t)

Sammanhörande titlar

Ingår i:BMC CancerLondon, United Kingdom : BioMed Central16:11471-2407

Internetlänk

Hitta via bibliotek

BMC Cancer (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

1 av 1
Föregående post
Nästa post
Till träfflistan

Hitta mer i SwePub

Av författaren/redakt...: Wimsatt, Jeffrey; Villers, Meghan; Thomas, Laurel; Kamarec, Stacey; Montgomery, Cait ...; Yeung, Leo W. Y. ...; visa fler...; Hu, Yanqing; Innes, Kim; visa färre...

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Cancer och onkol ...

Artiklar i publikationen: BMC Cancer

Av lärosätet: Örebro universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se